Self-reported Taste and Smell Disorders in Patients with COVID-19: Distinct Features in China

Abstract

Last December 2019, a cluster of viral pneumonia cases identified as coronavirus disease 2019 (COVID-19) was reported in Wuhan, China. We aimed to explore the frequencies of nasal symptoms in patients with COVID-19, including loss of smell and taste, as well as their presentation as the first symptom of the disease and their association with the severity of COVID-19. In this retrospective study, 1206 laboratory-confirmed COVID-19 patients were included and followed up by telephone one month after discharged from Tongji Hospital, Wuhan. Demographic data, laboratory values, comorbidities, symptoms, and numerical rating scale scores (0–10) of nasal symptoms were extracted from the hospital medical records, and confirmed or reevaluated by the telephone follow-up. From patients (n=1172) completing follow-up, 199 (17%) subjects had severe COVID-19 and 342 (29.2%) reported nasal symptoms. 20.6% COVID-19 patients had loss of taste (median score=6), while 11.4% had loss of smell (median score=5). Loss of taste scores, but not loss of smell scores, were significantly increased in severe vs. non-severe COVID-19 patients. Interleukin (IL)-6 and lactose dehydrogenase (LDH) serum levels were positively correlated with loss of taste scores. About 80% of COVID-19 patients recovered from smell and taste dysfunction in 2 weeks. In this cohort, only 1 out of 10 hospital admitted patients had loss of smell while 1 out of 5 reported loss of taste which was associated to severity of COVID-19. Most patients recovered smell and taste dysfunctions in 2 weeks.

References

[1] GuanWJ, NiZY, HuY, et al.. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med, 2020, 382(18): 1708-1720

[2] GiacomelliA, PezzatiL, ContiF, et al.. Self-reported Olfactory and Taste Disorders in Patients with Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study. Clin Infect Dis, 2020, 71(15): 889-890

[3] LechienJR, Chiesa-EstombaCM, De SiatiDR, et al.. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol, 2020, 277(8): 2251-2261

[4] YanCH, FarajiF, PrajapatiDP, et al.. Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms. Int Forum Allergy Rhinol, 2020, 10(7): 806-813

[5] RolandLT, GurrolaJG, LoftusPA, et al.. Smell and taste symptom-based predictive model for COVID-19 diagnosis. Int Forum Allergy Rhinol, 2020, 10(7): 832-838

[6] MaoL, JinH, WangM, et al.. Neurologic Manifestations of Hospitalized Patients with Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol, 2020, 77(6): 683-690

[7] WHO. Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected: interim guidance. January 28, 2020 (https://www.who.int/docs/default-source/coronaviruse/clinical-management-of-novel-cov.pdf).

[8] MetlayJP, WatererGW, LongAC, et al.. Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med, 2019, 200(7): e45-e67

[9] FokkensWJ, LundVJ, HopkinsC, et al.. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology, 2020, 58(SupplS29): 1-464

[10] ZengM, WangH, LiaoB, et al.. Comparison of efficacy of fluticasone propionate versus clarithromycin for postoperative treatment of different phenotypic chronic rhinosinusitis: a randomized controlled trial. Rhinology, 2019, 57(2): 101-109

[11] PellegrinoR, Walliczek-DworschakU, WinterG, et al.. Investigation of chemosensitivity during and after an acute cold. Int Forum Allergy Rhinol, 2017, 7(2): 185-91

[12] Guan WJ, Liang WH, Zhao Y, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J, 2020,55(5)

[13] ChengL, ChenJ, FuQ, et al.. Chinese Society of Allergy Guidelines for Diagnosis and Treatment of Allergic Rhinitis. Allergy Asthma Immunol Res, 2018, 10(4): 300-353

[14] ShiJB, FuQL, ZhangH, et al.. Epidemiology of chronic rhinosinusitis: results from a cross-sectional survey in seven Chinese cities. Allergy, 2015, 70(5): 533-539

[15] QinC, ZhouL, HuZ, et al.. Dysregulation of Immune Response in Patients with Coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis, 2020, 71(15): 762-768

[16] WangJH, KwonHJ, JangYJ. Detection of Parainfluenza Virus 3 in Turbinate Epithelial Cells of Postviral Olfactory Dysfunction Patients. Laryngoscope, 2007, 117(8): 1445-1449

[17] SuzukiM, SaitoK, MinWP, et al.. Identification of Viruses in Patients with Postviral Olfactory Dysfunction. The Laryngoscope, 2007, 117(2): 272-277

[18] MalhotraP, LukaA, McWilliamsCS, et al.. Clinical Features of Respiratory Viral Infections Among Inpatients at a Major US Tertiary Care Hospital. South Med J, 2016, 109(8): 481-486

[19] LuersJC, RokohlAC, LoreckN, et al.. Olfactory and Gustatory Dysfunction in Coronavirus Disease 2019 (COVID-19). Clin Infect Dis, 2020, 71(16): 2262-2264

[20] HwangCS. Olfactory neuropathy in severe acute respiratory syndrome: report of A case. Acta Neurol Taiwan, 2006, 15(1): 26-28

[21] Hummel T, Landis BN, Huttenbrink KB. Smell and taste disorders. GMS Curr Top Otorhinolaryngol Head Neck Surg, 2011,10:Doc04

[22] van RielD, VerdijkR, KuikenT. The olfactory nerve: a shortcut for influenza and other viral diseases into the central nervous system. J Pathol, 2015, 235(2): 277-287

[23] BaigAM, KhaleeqA, AliU, et al.. Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms. ACS Chem Neurosci, 2020, 11(7): 995-998

[24] MullolJ, AlobidI, Mariño-SánchezF, et al.. The Loss of Smell and Taste in the COVID-19 Outbreak: a Tale of Many Countries. Curr Allergy Asthma Rep, 2020, 20(10): 61

[25] Butowt R, von Bartheld CS. Anosmia in COVID-19: Underlying Mechanisms and Assessment of an Olfactory Route to Brain Infection. Neuroscientist, 2020, 073858420956905

[26] CooperKW, BrannDH, FarruggiaMC, et al.. COVID-19 and the Chemical Senses: Supporting Players Take Center Stage. Neuron, 2020, 107(2): 219-233

[27] NetlandJ, MeyerholzDK, MooreS, et al.. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J Virol, 2008, 82(15): 7264-7275

[28] XuH, ZhongL, DengJ, et al.. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci, 2020, 12(1): 8

[29] Wu C, Zheng S, Chen Y, et al. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCoV, in the nasal tissue. medRxiv, 2020, doi: https://doi.org/10.1101/2020.02.11.20022228

[30] KumarhiaD, HeL, McCluskeyLP. Inflammatory stimuli acutely modulate peripheral taste function. J Neurophysiol, 2016, 115(6): 2964-2975

[31] HenkinRI, SchmidtL, VelicuI. Interleukin 6 in Hyposmia. JAMA Otolaryngol Head Neck Surg, 2013, 139(7): 728-734

[32] SolerZM, PatelZM, TurnerJH, et al.. A primer on viral-associated olfactory loss in the era of COVID-19. Int Forum Allergy Rhinol, 2020, 10(7): 814-820

[33] Bousquet J, Akdis C, Jutel M, et al. Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement. Allergy, 2020, doi: https://doi.org/10.1111/011.14302